[
  "[Tab] Consolidated Statements of Cash Flows from Microchip Technology Incorporated and Subsidiaries\n\n[Time]: March 31, 2023 [SEP]\n[row 0]: Cash flows from operating activities: [SEP]\n[row 1]: Net income | $2,237.7 [SEP]\n[row 2]: Adjustments to reconcile net income to net cash provided by operating activities: [SEP]\n[row 3]: Depreciation and amortization | $998.4 [SEP]\n[row 4]: Deferred income taxes | $205.5 [SEP]\n[row 5]: Share-based compensation expense related to equity incentive plans | $170.4 [SEP]\n[row 6]: Loss on settlement of debt | $8.3 [SEP]\n[row 7]: Amortization of debt discount | $7.2 [SEP]\n[row 8]: Amortization of debt issuance costs | $9.5 [SEP]\n[row 9]: Impairment of intangible assets | $1.8 [SEP]\n[row 10]: Other non-cash adjustment | ($1.8) [SEP]\n[row 11]: Changes in operating assets and liabilities, excluding impact of acquisitions: [SEP]\n[row 12]: Increase in accounts receivable | ($232.7) [SEP]\n[row 13]: Increase (decrease) in inventories | ($483.2) [SEP]\n[row 14]: Increase in accounts payable and accrued liabilities | $323.4 [SEP]\n[row 15]: Change in other assets and liabilities | $404.5 [SEP]\n[row 16]: Change in income tax payable | ($28.0) [SEP]\n[row 17]: Net cash provided by operating activities | $3,621.2 [SEP]\n[row 18]: Cash flows from investing activities: [SEP]\n[row 19]: Proceeds from sales of assets | $0.9 [SEP]\n[row 20]: Investments in other assets | ($114.2) [SEP]\n[row 21]: Capital expenditures | ($486.2) [SEP]\n[row 22]: Net cash used in investing activities | ($599.5) [SEP]\n[row 23]: Cash flows from financing activities: [SEP]\n[row 24]: Proceeds from borrowings on Revolving Credit Facility | $5,935.0 [SEP]\n[row 25]: Repayments of Revolving Credit Facility | ($7,234.1) [SEP]\n[row 26]: Proceeds from issuance of senior notes | — [SEP]\n[row 27]: Repayment of senior notes | — [SEP]\n[row 28]: Repayment of Bridge Loan Facility | — [SEP]\n\n[row 28]: Repayments of Term Loan Facility | — [SEP]\n\n[row 29]: Payments on settlement of convertible debt | ($170.4) [SEP]\n[row 30]: Deferred financing costs | — [SEP]\n[row 31]: Purchase of capped call options | — [SEP]\n\n[row 31]: Proceeds from sale of common stock | $82.3 [SEP]\n\n[row 32]: Tax payments related to shares withheld for vested RSUs | ($75.8) [SEP]\n[row 33]: Repurchase of common stock | ($945.8) [SEP]\n[row 34]: Payment of cash dividends | ($695.3) [SEP]\n[row 35]: Capital lease payments | ($0.8) [SEP]\n[row 36]: Net cash used in financing activities | ($3,104.9) [SEP]\n[row 37]: Net (decrease) increase in cash and cash equivalents | ($83.4) [SEP]\n[row 38]: Cash and cash equivalents, and restricted cash at beginning of period | $317.4 [SEP]\n[row 39]: Cash and cash equivalents, and restricted cash at end of period | $234.0 [SEP]\n[row 40]: Supplemental disclosure of cash flow information: [SEP]\n[row 41]: Non-cash activities: [SEP]\n[row 42]: ROU assets obtained in exchange of lease liabilities | $38.4 [SEP]\n[row 43]: Cash paid for: [SEP]\n\n[Time]: March 31, 2022 [SEP]\n[row 0]: Cash flows from operating activities: [SEP]\n[row 1]: Net income | $1,285.5 [SEP]\n[row 2]: Adjustments to reconcile net income to net cash provided by operating activities: [SEP]\n[row 3]: Depreciation and amortization | $1,143.5 [SEP]\n[row 4]: Deferred income taxes | $7.9 [SEP]\n[row 5]: Share-based compensation expense related to equity incentive plans | $210.2 [SEP]\n[row 6]: Loss on settlement of debt | $113.4 [SEP]\n[row 7]: Amortization of debt discount | $44.9 [SEP]\n[row 8]: Amortization of debt issuance costs | $11.5 [SEP]\n[row 9]: Impairment of intangible assets | $3.0 [SEP]\n[row 10]: Other non-cash adjustment | ($11.4) [SEP]\n[row 11]: Changes in operating assets and liabilities, excluding impact of acquisitions: [SEP]\n[row 12]: Increase in accounts receivable | ($74.9) [SEP]\n[row 13]: Increase (decrease) in inventories | ($177.8) [SEP]\n[row 14]: Increase in accounts payable and accrued liabilities | $192.7 [SEP]\n[row 15]: Change in other assets and liabilities | $79.4 [SEP]\n[row 16]: Change in income tax payable | $14.8 [SEP]\n[row 17]: Net cash provided by operating activities | $2,842.7 [SEP]\n[row 18]: Cash flows from investing activities: [SEP]\n[row 19]: Proceeds from sales of assets | $14.1 [SEP]\n[row 20]: Investments in other assets | ($121.7) [SEP]\n[row 21]: Capital expenditures | ($370.1) [SEP]\n[row 22]: Net cash used in investing activities | ($477.7) [SEP]\n[row 23]: Cash flows from financing activities: [SEP]\n[row 24]: Proceeds from borrowings on Revolving Credit Facility | $4,176.0 [SEP]\n[row 25]: Repayments of Revolving Credit Facility | ($5,123.5) [SEP]\n[row 26]: Proceeds from issuance of senior notes | $977.0 [SEP]\n[row 27]: Repayment of senior notes | ($1,000.0) [SEP]\n[row 28]: Repayment of Bridge Loan Facility | — [SEP]\n\n[row 28]: Repayments of Term Loan Facility | — [SEP]\n\n[row 29]: Payments on settlement of convertible debt | ($424.7) [SEP]\n[row 30]: Deferred financing costs | ($8.5) [SEP]\n[row 31]: Purchase of capped call options | — [SEP]\n\n[row 31]: Proceeds from sale of common stock | $70.5 [SEP]\n\n[row 32]: Tax payments related to shares withheld for vested RSUs | ($84.2) [SEP]\n[row 33]: Repurchase of common stock | ($425.6) [SEP]\n[row 34]: Payment of cash dividends | ($503.8) [SEP]\n[row 35]: Capital lease payments | ($0.8) [SEP]\n[row 36]: Net cash used in financing activities | ($2,327.6) [SEP]\n[row 37]: Net (decrease) increase in cash and cash equivalents | $37.4 [SEP]\n[row 38]: Cash and cash equivalents, and restricted cash at beginning of period | $280.0 [SEP]\n[row 39]: Cash and cash equivalents, and restricted cash at end of period | $317.4 [SEP]\n[row 40]: Supplemental disclosure of cash flow information: [SEP]\n[row 41]: Non-cash activities: [SEP]\n[row 42]: ROU assets obtained in exchange of lease liabilities | $27.5 [SEP]\n[row 43]: Cash paid for: [SEP]"
]